A detailed history of Cva Family Office, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cva Family Office, LLC holds 174 shares of EW stock, worth $11,751. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174
Previous 1,802 90.34%
Holding current value
$11,751
Previous $166,000 93.37%
% of portfolio
0.0%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$59.7 - $93.78 $97,191 - $152,673
-1,628 Reduced 90.34%
174 $11,000
Q2 2024

Jul 09, 2024

SELL
$84.3 - $94.31 $7,165 - $8,016
-85 Reduced 4.5%
1,802 $166,000
Q4 2023

Jan 16, 2024

BUY
$61.71 - $77.76 $116,446 - $146,733
1,887 New
1,887 $143,000
Q2 2023

Jul 10, 2023

BUY
$81.41 - $94.33 $651 - $754
8 Added 0.37%
2,199 $207,000
Q1 2023

Apr 26, 2023

BUY
$74.26 - $84.51 $162,703 - $185,161
2,191 New
2,191 $181,000
Q3 2022

Nov 22, 2022

SELL
$82.37 - $107.29 $98,020 - $127,675
-1,190 Reduced 42.29%
1,624 $134,000
Q2 2022

Jul 11, 2022

BUY
$86.5 - $128.27 $60,117 - $89,147
695 Added 32.8%
2,814 $268,000
Q1 2022

Apr 22, 2022

BUY
$101.96 - $128.34 $34,666 - $43,635
340 Added 19.11%
2,119 $249,000
Q4 2021

Jan 25, 2022

BUY
$106.37 - $130.68 $114,241 - $140,350
1,074 Added 152.34%
1,779 $230,000
Q3 2021

Oct 12, 2021

SELL
$102.91 - $122.75 $140,369 - $167,431
-1,364 Reduced 65.93%
705 $56,000
Q2 2021

Jul 13, 2021

BUY
$83.84 - $104.76 $78,725 - $98,369
939 Added 83.1%
2,069 $214,000
Q1 2021

Apr 14, 2021

BUY
$78.68 - $90.67 $33,439 - $38,534
425 Added 60.28%
1,130 $95,000
Q3 2020

Oct 27, 2020

BUY
$67.19 - $87.44 $27,211 - $35,413
405 Added 135.0%
705 $56,000
Q2 2020

Jul 31, 2020

BUY
$57.54 - $76.95 $17,262 - $23,085
300 New
300 $21,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.